We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XENE icon
9301
CALL
Xenon Pharmaceuticals
XENE
$6.03B
$359K ﹤0.01%
+11,800
New +$357K
XMVM icon
9302
Invesco S&P MidCap Value with Momentum ETF
XMVM
$513M
$359K ﹤0.01%
+9,135
New +$402K
YPS
9303
DELISTED
Arrow Reverse Cap 500 ETF
YPS
$359K ﹤0.01%
+18,018
New +$396K
REV
9304
PUT
DELISTED
Revlon, Inc.
REV
$359K ﹤0.01%
66,200
+41,400
+167% +$227K
ALGT icon
9305
Allegiant Air
ALGT
$2.34B
$358K ﹤0.01%
3,169
+696
+28% +$100K
ALSN icon
9306
PUT
Allison Transmission
ALSN
$10.4B
$358K ﹤0.01%
9,300
-10,800
-54% -$413K
CRBU icon
9307
Caribou Biosciences
CRBU
$169M
$358K ﹤0.01%
65,975
-291,526
-82% -$2.23M
HMY icon
9308
PUT
Harmony Gold Mining
HMY
$12.1B
$358K ﹤0.01%
114,300
-38,300
-25% -$147K
ITGR icon
9309
Integer Holdings
ITGR
$4.26B
$358K ﹤0.01%
5,072
-42,953
-89% -$3.28M
JBI icon
9310
CALL
Janus International
JBI
$697M
$358K ﹤0.01%
+39,700
New +$385K
PAM icon
9311
CALL
Pampa Energía
PAM
$4.23B
$358K ﹤0.01%
17,500
-6,400
-27% -$142K
BARK icon
9312
CALL
BARK
BARK
$91.4M
$357K ﹤0.01%
13,945
+1,080
+8% +$54.5K
BIPC icon
9313
CALL
Brookfield Infrastructure
BIPC
$4.97B
$357K ﹤0.01%
8,400
-4,500
-35% -$213K
CNTB
9314
Connect Biopharma Holdings
CNTB
$161M
$357K ﹤0.01%
+409,659
New +$603K
DOYU
9315
DouYu International Holdings
DOYU
$142M
$357K ﹤0.01%
+29,714
New +$455K
FBT icon
9316
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.77B
$357K ﹤0.01%
2,630
-41,574
-94% -$5.73M
RNAC icon
9317
Cartesian Therapeutics
RNAC
$267M
$357K ﹤0.01%
9,071
-1,140
-11% -$33.8K
VFF icon
9318
CALL
Village Farms International
VFF
$309M
$357K ﹤0.01%
136,800
-46,900
-26% -$170K
WOR icon
9319
PUT
Worthington Enterprises
WOR
$2.87B
$357K ﹤0.01%
13,138
-29,683
-69% -$860K
SAIL
9320
PUT
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
$357K ﹤0.01%
5,700
-25,000
-81% -$1.54M
APEI icon
9321
American Public Education
APEI
$828M
$356K ﹤0.01%
22,002
-3,277
-13% -$55.8K
APT icon
9322
CALL
Alpha Pro Tech
APT
$55.4M
$356K ﹤0.01%
79,800
-75,100
-48% -$320K
KRNY icon
9323
Kearny Financial
KRNY
$605M
$356K ﹤0.01%
32,019
+16,103
+101% +$193K
TM icon
9324
Toyota
TM
$226B
$356K ﹤0.01%
2,310
-7,374
-76% -$1.22M
FUV
9325
DELISTED
Arcimoto, Inc. Common Stock
FUV
$356K ﹤0.01%
+5,438
New +$431K

Similar funds

Ken Griffin's Q2 2022 Portfolio in Review

As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.